Beyond market averages, investors looking for exceptional returns turn to stock picking. Skillful choices in individual stocks have the power to substantially increase your wealth.
The closing price of GE HealthCare Technologies Inc (NASDAQ: GEHC) was $75.33 for the day, up 1.24% from the previous closing price of $74.41. In other words, the price has increased by $1.24 from its previous closing price. On the day, 3.02 million shares were traded. GEHC stock price reached its highest trading level at $75.44 during the session, while it also had its lowest trading level at $74.315.
Ratios:
Our analysis of GEHC’s different ratios will help us gain a deeper understanding of the company. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 9.14 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 21.98. For the most recent quarter (mrq), Quick Ratio is recorded 0.89 and its Current Ratio is at 1.12. In the meantime, Its Debt-to-Equity ratio is 1.10 whereas as Long-Term Debt/Eq ratio is at 0.88.
On March 11, 2025, Goldman Upgraded its rating to Buy which previously was Neutral and also upped its target price recommendation from $85 to $100.
Jefferies Upgraded its Hold to Buy on January 08, 2025, whereas the target price for the stock was revised from $95 to $103.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Feb 18 ’25 when Newcomb George A. sold 2,000 shares for $92.54 per share. The transaction valued at 185,080 led to the insider holds 7,462 shares of the business.
Rott Roland sold 3,577 shares of GEHC for $309,339 on Nov 06 ’24. The CEO, Imaging now owns 24,298 shares after completing the transaction at $86.48 per share. On Nov 06 ’24, another insider, Roland Rott, who serves as the Officer of the company, bought 3,577 shares for $86.48 each.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, GEHC now has a Market Capitalization of 34392813568 and an Enterprise Value of 41612816384. As of this moment, GE’s Price-to-Earnings (P/E) ratio for their current fiscal year is 15.42, and their Forward P/E ratio for the next fiscal year is 15.26. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 2.15. For the stock, the TTM Price-to-Sale (P/S) ratio is 1.72 while its Price-to-Book (P/B) ratio in mrq is 3.54. Its current Enterprise Value per Revenue stands at 2.084 whereas that against EBITDA is 11.326.
Stock Price History:
The Beta on a monthly basis for GEHC is 1.28, which has changed by -0.11688161 over the last 52 weeks, in comparison to a change of 0.16657472 over the same period for the S&P500. Over the past 52 weeks, GEHC has reached a high of $94.80, while it has fallen to a 52-week low of $57.65. The 50-Day Moving Average of the stock is 2.20%, while the 200-Day Moving Average is calculated to be -3.93%.
Shares Statistics:
GEHC traded an average of 3.78M shares per day over the past three months and 4049960 shares per day over the past ten days. A total of 456.56M shares are outstanding, with a floating share count of 455.30M. Insiders hold about 0.28% of the company’s shares, while institutions hold 77.77% stake in the company. Shares short for GEHC as of 1753920000 were 9024652 with a Short Ratio of 2.39, compared to 1751241600 on 7875137. Therefore, it implies a Short% of Shares Outstanding of 9024652 and a Short% of Float of 2.6099999.
Dividends & Splits
With its trailing 12-month dividend rate of 0.1, GEHC has a forward annual dividend rate of 0.14. Against a Trailing Annual Dividend Yield of 0.0013439053
Earnings Estimates
The performance of GE HealthCare Technologies Inc (GEHC) in the stock market is under the watchful eye of 14.0 analysts actively contributing to its current rating.The consensus estimate for the next quarter is $1.39, with high estimates of $1.43 and low estimates of $1.34.
Analysts are recommending an EPS of between $4.55 and $4.26 for the fiscal current year, implying an average EPS of $4.51. EPS for the following year is $4.84, with 19.0 analysts recommending between $5.13 and $4.05.
Revenue Estimates
It is expected that $90B in revenue will be generated in the current quarter, according to 13 analysts. It ranges from a high estimate of $5.11B to a low estimate of $5.01B. As of the current estimate, GE HealthCare Technologies Inc’s year-ago sales were $4.86BFor the next quarter, 13 analysts are estimating revenue of $5.61B. There is a high estimate of $5.68B for the next quarter, whereas the lowest estimate is $5.53B.
A total of 19 analysts have provided revenue estimates for GEHC’s current fiscal year. The highest revenue estimate was $20.58B, while the lowest revenue estimate was $20.08B, resulting in an average revenue estimate of $20.42B. In the same quarter a year ago, actual revenue was $19.67BBased on 19 analysts’ estimates, the company’s revenue will be $21.35B in the next fiscal year. The high estimate is $21.71B and the low estimate is $20.78B.
